Dipendenti a tempo pieno
2300
Settore GIC
Health Care
Gruppo GIC
Pharmaceuticals, Biotechnology & Life Sciences
Settore
Drug Manufacturers - Specialty & Generic
Nome
Titolo
Anno di nascita
Mr. Brad Asher
Chief Financial Officer
-
Mr. James Robert Mendola
Interim Co-Chief Revenue Officer
-
Paul Fisher
Chief Transformation Officer
-
Mr. Steven Michael Cohen J.D.
Interim Chief Executive Officer
1963
George Frank DeNardo
Chief Operating Officer
-
Mr. Sarvesh Mathur
Chief Technology Officer
-
Ms. Anya Varga
Chief People Officer
-
Mark Bruno
Senior Vice President of Cultivation
-
Khari Edwards
Head of CSR
-
Ms. Julie Winter
Interim Co-Chief Revenue Officer
-